مؤتمر
Phase 1/2a trial of nadunolimab, a first-in-class fully humanized monoclonal antibody against IL1RAP, in combination with gemcitabine and nab-paclitaxel (GN) in patients with pancreatic adenocarcinoma (PDAC).
| العنوان: | Phase 1/2a trial of nadunolimab, a first-in-class fully humanized monoclonal antibody against IL1RAP, in combination with gemcitabine and nab-paclitaxel (GN) in patients with pancreatic adenocarcinoma (PDAC). |
|---|---|
| المؤلفون: | Van Cutsem, Eric, Eefsen, Rikke Lovendahl, Ochsenreither, Sebastian, Zvirbule, Zanete, Ivanauskas, Audrius, Arnold, Dirk, Baltruskeviciene, Edita, Pfeiffer, Per, Yachnin, Jeffrey, Garcia Carbonero, Rocio, Greil, Richard, Jungels, Christiane, Poulsen, Laurids, Awada, Ahmad, Garcia Ribas, Ignacio, Losic, Nedjad, Collignon, Joelle |
| المصدر: | Van Cutsem , E , Eefsen , R L , Ochsenreither , S , Zvirbule , Z , Ivanauskas , A , Arnold , D , Baltruskeviciene , E , Pfeiffer , P , Yachnin , J , Garcia Carbonero , R , Greil , R , Jungels , C , Poulsen , L , Awada , A , Garcia Ribas , I , Losic , N & Collignon , J 2022 , ' Phase 1/2a trial of nadunolimab, a first-in-class fully humanized monoclonal antibody against IL1RAP, in combination with gemcitabine and nab-paclitaxel (GN) in patients with pancreatic adenocarcinoma .... |
| سنة النشر: | 2022 |
| المجموعة: | Aalborg University (AAU): Publications / Aalborg Universitet: Publikationer |
| نوع الوثيقة: | conference object |
| اللغة: | English |
| العلاقة: | https://vbn.aau.dk/da/publications/41e10015-43bf-4647-9aaa-eb976c04badaTest |
| DOI: | 10.1200/JCO.2022.40.16_suppl.4141 |
| الإتاحة: | https://doi.org/10.1200/JCO.2022.40.16_suppl.4141Test https://vbn.aau.dk/da/publications/41e10015-43bf-4647-9aaa-eb976c04badaTest |
| حقوق: | info:eu-repo/semantics/closedAccess |
| رقم الانضمام: | edsbas.FCB9A5EC |
| قاعدة البيانات: | BASE |
| DOI: | 10.1200/JCO.2022.40.16_suppl.4141 |
|---|